What question did this study set out to answer?

To summarize the clinical indications, dosing, and monitoring of heparin with a focus on specific populations.

March 15, 2026BiomoleculesOpen Access

Heparin Anticoagulant Therapy and Its Monitoring

View Full Paper

Ask AI

Bookmark

To summarize the clinical indications, dosing, and monitoring of heparin with a focus on specific populations.
Narrative review of heparin therapy and monitoring techniques in acute and chronic care settings.
Discussion of laboratory monitoring methods including APTT, anti-factor Xa, ACT, and VET.
Review of complications and considerations in specific populations such as pregnant women and cardiac patients.
Heparin remains a foundational therapy in anticoagulation, with specific indications for UFH and LMWH.
Discussion on monitoring challenges and potential interferences in laboratory tests.
Identified common complications like heparin resistance and heparin-induced thrombocytopenia (HIT).

Implication

Narrative review highlights anticoagulant therapy's impact on heparin-induced thrombocytopenia, suggesting improved monitoring strategies for ECMO.

Abstract

Heparin remains a foundational parenteral anticoagulant across both acute and chronic care settings. This narrative review summarizes clinical indications and dosing of unfractionated (UFH) and low-molecular-weight heparin (LMWH). It also details laboratory monitoring using activated partial thromboplastin (APTT), anti-factor Xa (anti-Xa), activated clotting time (ACT) and viscoelastic testing (VET), including common pitfalls and interferences. We provide considerations for specific populations as well as complications including heparin resistance, heparin-induced thrombocytopenia (HIT) and heparin reversal strategies. Future research directions include harmonization of therapeutic ranges, mitigation of assay interference and prospective evaluation on monitoring, particular in extracorporeal membrane oxygenation (ECMO), pregnancy and cardiac surgical settings.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Reardon et al. (2026) studied this question.

synapsesocial.com/papers/69b606af83145bc643d1ce33 https://doi.org/10.3390/biom16030425

View Full Paper

Ask AI

Bookmark

Implication

Narrative review highlights anticoagulant therapy's impact on heparin-induced thrombocytopenia, suggesting improved monitoring strategies for ECMO.

Heparin Anticoagulant Therapy and Its Monitoring

Key Points

Implication

Abstract

Discussion

Cite This Study

Heparin Anticoagulant Therapy and Its Monitoring

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading